Bartholomew Andrew Martyak, MD | |
3417 Busch St, Butte, MT 59701-3505 | |
(406) 541-3937 | |
(406) 541-1810 |
Full Name | Bartholomew Andrew Martyak |
---|---|
Gender | Male |
Speciality | Ophthalmology |
Location | 3417 Busch St, Butte, Montana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1073508669 | NPI | - | NPPES |
101626 | Medicaid | MT |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207W00000X | Ophthalmology | 7395 (Montana) | Primary |
Mailing Address | Practice Location Address |
---|---|
Bartholomew Andrew Martyak, MD Po Box 4907, 700 West Kent, Missoula, MT 59806-4907 Ph: (406) 541-3937 | Bartholomew Andrew Martyak, MD 3417 Busch St, Butte, MT 59701-3505 Ph: (406) 541-3937 |
News Archive
According to the National Council of Aging, approximately 92 percent of seniors have at least one chronic disease and 77 percent have at least two.
UT Southwestern Medical Center researchers, collaborating with colleagues in Germany, have for the first time identified antibodies associated with transplant rejection of otherwise healthy kidneys.
Home Diagnostics, Inc., a leading manufacturer and marketer of diabetes testing supplies, announced today that it signed a definitive merger agreement with Nipro Corporation (Tokyo Stock Exchange and Osaka Stock Exchange Ticker Code 8086), a global manufacturer and distributor of medical devices, pharmaceutical products and medical and glass products headquartered in Osaka, Japan, under which Nipro will acquire all outstanding shares of Home Diagnostics' common stock, $.01 par value, for a cash purchase price of $11.50 per share (or aggregate consideration of approximately $215 million).
New analysis presented at the Transcatheter Cardiovascular Therapeutics meeting (TCT 2010) in Washington, DC, indicates that the broad use of CYPHER Sirolimus-eluting coronary stent in patients with diabetes would result in substantial cost savings, as compared to the use of everolimus-eluting stents (EES), paclitaxel-eluting stents (PES), or zotarolimus-eluting stents (ZES).
› Verified 6 days ago
Dr. Robert Ian Noble, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 832 S Montana St, Butte, MT 59701 Phone: 406-723-4004 | |
Dr. David G Shapnick, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 401 S Alabama St, Butte, MT 59701 Phone: 406-782-3808 Fax: 406-782-3802 | |
Clay Daniel Holley, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3417 Busch St, Butte, MT 59701 Phone: 406-494-3145 | |
Dr. Richard T Tschetter, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 832 S Montana St, Butte, MT 59701 Phone: 406-723-4004 Fax: 406-782-4567 |